Parikshit Somani's Four-Year Ban: When the "Food Contamination" Defence Stops Holding Up

At a lower-tier tennis event in Astana, Kazakhstan, a urine sample from a 26-year-old Indian doubles player tested positive for trimetazidine. A year later, in London, an independent tribunal convened by the International Tennis Integrity Agency published its verdict: Parikshit Somani is suspended for four years, until September 2029.

Somani is not a familiar name on any ranking list. His career-high is No. 256 in the world, and that was in doubles. He played events with empty stands, few officials, and prize money that rarely covered a plane ticket. Most doping cases in professional tennis happen at this level, and at this level they attract the least attention.

Four years is the maximum under the Tennis Anti-Doping Programme for a first violation with no mitigating circumstances. During the suspension, Somani cannot play, coach, or attend any event organised by World Tennis, the WTA, the ATP, the Grand Slams, or any national federation. The door closes on him as a player and as a member of the system.

Context: one substance, three continents

Trimetazidine is a cardiac medication prescribed to reduce angina, working by altering how the body metabolises energy. On the World Anti-Doping Agency list, it sits in the group of hormones and metabolic modulators. For athletes, the suggested effect is improved tolerance when the body is short of oxygen.

The name became a global headline in February 2026, when Russian figure skater Kamila Valieva, then 15, was found to have the substance in a sample collected in December 2026 but revealed while she was competing at the Beijing Winter Olympics. The case shook an entire Olympic Games. Valieva was allowed to skate the women's singles after a Court of Arbitration for Sport ruling, but she fell in the free programme and left Beijing in tears. She was later banned for four years as well.

Eight years earlier, in 2026, Chinese swimmer Sun Yang tested positive for trimetazidine in a case that drew heavy controversy. He served a three-month ban after arguing he was treating chest pain and did not know the substance was prohibited.

What links all three cases is a technical detail that rarely gets mentioned. Trimetazidine is not a substance an athlete can easily ingest accidentally through ordinary food. Natural concentrations in food are considered negligible. Published pharmacokinetic data put its half-life at roughly six to seven hours in people with normal kidney function. For the substance to be detectable in a urine sample, ingestion must sit relatively close to the collection, not weeks before. That is why the "food contamination" explanation sits among the hardest defences to sustain at a doping hearing.

Three adjectives, three gaps

The Somani hearing took place in August. His argument: the banned substance entered his body through food prepared by a family member who was taking a trimetazidine-containing medicine, and the medicine got into what he ate.

Reading that, I remembered the evenings I spent going back through the published documents of the Valieva case. Her legal team in 2026 offered a similar argument: the substance entered through food prepared by her grandfather, who was being treated with trimetazidine. Two cases, two continents, two sports, two different family settings, and one identical argument structure.

The tribunal in Somani's case did not accept it. According to the ITIA statement, the judges concluded the food contamination theories were "scientifically implausible", "highly speculative" and "unconvincing". Those three adjectives are carefully chosen, and each targets a different gap.

"Scientifically implausible" attacks the mechanism. For a contamination argument to hold, the respondent must build a specific causal chain: what medicine the relative took, at what dose, at what time, how it entered the food, how much contaminated food the athlete consumed, and what concentration remained in the body afterwards. The longer the chain, the easier it breaks in the middle.

"Highly speculative" attacks the evidence. A respondent does not have to prove something with absolute certainty, but must present a version of events with more basis than a random hypothesis. When an explanation rests on "it could be", "perhaps", "I think", it loses weight on its own.

"Unconvincing" is the verdict on the whole story, after the first two layers of scrutiny have already failed.

One point about the rules deserves clarity. The tennis anti-doping system operates on strict liability: athletes are responsible for anything in their body, whether they knew about it or not. The task is not to prove cheating but to prove the source. That is why the burden in cases like this always sits with the athlete.

The contrarian angle: a class problem in tennis

The story is usually told in a familiar direction: another athlete caught, another excuse. But there is an aspect rarely discussed, and it sits not in the verdict but in living conditions.

A top-20 player has a private kitchen, a nutritionist, a compliance team that reads the label of every supplement before it enters the body. For them, cross-contamination risk is close to zero, not because they are more ethical, but because they can afford safety.

A world No. 256 in doubles lives in shared housing, eats home-cooked meals, buys food at local markets, and typically has no personal doctor to call. For them, cross-contamination is a structural risk rather than a choice.

A four-year ban applies equally to both groups. That is correct under the rules. It also exposes a paradox: the system treats equally people who are utterly unequal in defensive resources. A top player can hire lawyers, commission independent experts to reconstruct a causal chain, pay a lab to test food samples. Somani had almost none of that.

This is not an argument to reduce the sanction. Trimetazidine is on the prohibited list, and rules are rules. But when reading a four-year ban, the right question is not "is he guilty" but "was he able to defend himself".

The numbers do not lie. You just have to ask the right question.

Across the doping cases I have followed in several sports since 2026, a pattern repeats: cross-contamination arguments appear frequently, are accepted rarely, and the cases that are accepted almost always involve athletes with strong legal teams. That is an observation from what is publicly visible, not a complete statistical conclusion, but it is enough to make me pause before quick judgement.

What to watch next

Some things only emerge when you sit still longer than one set. Here, the signal to watch is not the sanction but the tribunal's full reasoned decision, if it is published. The ITIA summary says the judges rejected the contamination argument, but does not detail the scientific evidence they relied on, nor what documents the respondent submitted.

If the system continues to publish conclusions without reasoning, trust in the process will keep eroding on both sides. For the player, it is the sense that they can never win. For the audience, it is the sense that every verdict may have been written in advance.

Fans are entitled to live in emotion; my job is to live in data. And the data at this point supports only one statement: a 26-year-old player, career-high No. 256 in doubles, will not compete until September 2029. Whether that stretch matches anything that was proven, or anything that was not, remains an open question.